By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Upsher-Smith Laboratories, Inc. 

14905 23rd Avenue North

Minneapolis  Minnesota  55447  U.S.A.
Phone: 800-328-3344 Fax:


Company News
Upsher-Smith Laboratories's ANDROXY (Fluoxymesterone Tablets, USP) CIII Now Available 7/27/2015 11:24:47 AM
Upsher-Smith Laboratories Release: FDA Approves Expanded Indication For Qudexy XR (Topiramate) Extended-Release Capsules Within The Pediatric Population 6/1/2015 7:30:06 AM
Upsher-Smith Laboratories Research On Qudexy XR (topiramate) Extended-Release Capsules Highlighted At the 2015 American Academy of Neurology Annual Meeting 4/21/2015 11:34:31 AM
Upsher-Smith Laboratories To Present Data Evaluating The Long-Term Safety And Efficacy Of Qudexy XR (Topiramate) Extended-Release Capsules And Alternative Administration Techniques 4/13/2015 7:54:25 AM
Upsher-Smith Laboratories To Debut I Hate Seizures Campaign At Ninth Annual National Walk For Epilepsy 4/10/2015 10:50:23 AM
Upsher-Smith Laboratories Honors 45 Innovative Pharmacists From Across The Nation 2/24/2015 10:24:58 AM
Upsher-Smith Laboratories's Vogelxo (Testosterone) Gel 1% (Tubes and Packets) Receives AB-Rating To Testim From FDA 2/10/2015 11:34:28 AM
Upsher-Smith Laboratories Launches Patient Savings And Support Program For Qudexy XR (Topiramate) Extended-Release Capsules 2/9/2015 9:45:32 AM
Upsher-Smith Laboratories Release: Systematic Review Presented At 68th Annual Meeting Of The American Epilepsy Society Points To Need For Expert Consensus On Seizure Cluster Nomenclature And Diagnosis 12/8/2014 9:01:30 AM
Upsher-Smith Laboratories Presents New Data From Year-Long, Open-Label Extension Study Of Qudexy XR (Topiramate) Extended-Release Capsules At 68th Annual American Epilepsy Society Meeting 12/8/2014 8:59:45 AM